Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 06 Mar 2023
USA: The syrup drug Diethylene glycol (DEG), a drug commonly used to prevent infections, is the cause of kidney disease...
Read Full NewsDr Maurie Markman discusses why smoking cessation remains a critical clinical priority for improving mortality risk in patients with advanced cancer.
Dr George Lundberg explains why treating equity as a banned political buzzword undermines the very foundations of public health and medical care.
Insights from AUA 2026, including anticipated presentations, key takeaways, and how new research in metastatic prostate cancer will affect patient care.
Patients’ experience of pain during birth and ob/gyn procedures may relate to a perceived loss of control or a clinician’s lack of concern.
A small pilot study found that selectively filtering circulating protein sFlt-1 from maternal blood was safe and prolonged pregnancy in women with very preterm preeclampsia.
A new HHS action plan aims to curb psychiatric drug “overprescribing” and expand nonmedication mental health care, drawing criticism from the APA.
The use of nucleic acid synthesis inhibitors or sphingosine-1-phosphate modulators, fumarates, or interferons is linked to a lower risk for noninfectious uveitis in patients with MS, a new study finds.
1.
The First Gene Therapy Provides a Durable Response for Non-Muscle-Invasive Bladder Cancer.
2.
Dense breasts: What it means and what women can do about screening
3.
The response of bipolar patients to lithium may be predicted by ancestry.
4.
AZD0486 Shows Good Efficacy in Relapsed/Refractory Follicular Lymphoma
5.
The Risk of Major Mortality is Associated with the Start of Opioids in Dementia.
1.
Can We Repurpose BV-CHP for Better Outcomes in Peripheral T-Cell Lymphoma?
2.
Understanding Mesenteric Masses: Symptoms, Diagnosis, and Treatment Options
3.
Unlocking the Power of Hematocrit: Exploring the Benefits of Blood Cell Counts
4.
Inside Oncology Trials: From Protocol to Progress in Cancer Research and Care
5.
Radiation in Oncology: Advances, Applications, and Accessibility
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
5.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge